Because Kv11.1/hERG channel is impaired in inherited or drug-induced acquired long QT syndrome, many hERG activators have been developed and some of those effectively exert antiarrhythmic action (Su et al., 2021). This evidence concerns the gene KCNH2 and acquired long QT syndrome.